Skip to main navigation
Skip to search
Skip to main content
UNT Health Home
Search content at UNT Health
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Beta-Adrenergic Blockade and Voice: A Double-Blind, Placebo-Controlled Trial
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Beta-Adrenergic Blockade and Voice: A Double-Blind, Placebo-Controlled Trial'. Together they form a unique fingerprint.
Placebo
Neuroscience
100%
Beta Adrenergic Receptor Blocking
Neuroscience
100%
Propranolol
Neuroscience
100%
Hypertensive Factor
Pharmacology, Toxicology and Pharmaceutical Science
100%
Sympathetic Nervous System
Neuroscience
50%
Cardiovascular System
Neuroscience
12%
Aerodynamic Parameters
Keyphrases
10%
Voice Measures
Keyphrases
10%
Cite this